Article
The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis.
Mayo Clinic proceedings - 1 Jul 2005
Tefferi Ayalew, Gilliland D Gary
Abstract excerpt
Janus kinase 2 (JAK2) is a cytoplasmic protein-tyrosine kinase that catalyzes the transfer of the gamma-phosphate group of adenosine triphosphate to the hydroxyl groups of specific tyrosine residues in signal transduction molecules. JAK2 mediates signaling downstream of cytokine receptors after l...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
